1. Home
  2. TKNO vs ERC Comparison

TKNO vs ERC Comparison

Compare TKNO & ERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • ERC
  • Stock Information
  • Founded
  • TKNO 1996
  • ERC 2003
  • Country
  • TKNO United States
  • ERC United States
  • Employees
  • TKNO N/A
  • ERC N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • ERC Finance/Investors Services
  • Sector
  • TKNO Health Care
  • ERC Finance
  • Exchange
  • TKNO Nasdaq
  • ERC Nasdaq
  • Market Cap
  • TKNO 244.7M
  • ERC N/A
  • IPO Year
  • TKNO 2021
  • ERC N/A
  • Fundamental
  • Price
  • TKNO $5.45
  • ERC $9.40
  • Analyst Decision
  • TKNO Buy
  • ERC
  • Analyst Count
  • TKNO 2
  • ERC 0
  • Target Price
  • TKNO $5.00
  • ERC N/A
  • AVG Volume (30 Days)
  • TKNO 122.3K
  • ERC 64.4K
  • Earning Date
  • TKNO 11-07-2024
  • ERC 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • ERC 8.37%
  • EPS Growth
  • TKNO N/A
  • ERC N/A
  • EPS
  • TKNO N/A
  • ERC 0.72
  • Revenue
  • TKNO $34,940,000.00
  • ERC N/A
  • Revenue This Year
  • TKNO $3.22
  • ERC N/A
  • Revenue Next Year
  • TKNO $14.88
  • ERC N/A
  • P/E Ratio
  • TKNO N/A
  • ERC $12.92
  • Revenue Growth
  • TKNO N/A
  • ERC N/A
  • 52 Week Low
  • TKNO $1.16
  • ERC $8.51
  • 52 Week High
  • TKNO $5.47
  • ERC $9.74
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 62.45
  • ERC 47.52
  • Support Level
  • TKNO $4.76
  • ERC $9.31
  • Resistance Level
  • TKNO $5.07
  • ERC $9.47
  • Average True Range (ATR)
  • TKNO 0.36
  • ERC 0.06
  • MACD
  • TKNO 0.02
  • ERC -0.02
  • Stochastic Oscillator
  • TKNO 98.27
  • ERC 33.33

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Share on Social Networks: